318 related articles for article (PubMed ID: 36140280)
1. Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics.
Leong EWX; Ge R
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140280
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
3. Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs.
Li Y; Ye Z; Yang H; Xu Q
Acta Pharm Sin B; 2022 Jun; 12(6):2624-2639. PubMed ID: 35755280
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of
Jung HN; Lee SY; Lee S; Youn H; Im HJ
Theranostics; 2022; 12(17):7509-7531. PubMed ID: 36438494
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Lipid Nanoparticles for Delivery of mRNA.
Yang L; Gong L; Wang P; Zhao X; Zhao F; Zhang Z; Li Y; Huang W
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559175
[TBL] [Abstract][Full Text] [Related]
7. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.
Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ
Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955
[TBL] [Abstract][Full Text] [Related]
8. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
Okuda T; Okamoto H
Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
Battaglia L; Gallarate M
Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route.
Ongun M; Lokras AG; Baghel S; Shi Z; Schmidt ST; Franzyk H; Rades T; Sebastiani F; Thakur A; Foged C
Eur J Pharm Biopharm; 2024 May; 198():114266. PubMed ID: 38499255
[TBL] [Abstract][Full Text] [Related]
11. Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery.
Khan MS; Baskoy SA; Yang C; Hong J; Chae J; Ha H; Lee S; Tanaka M; Choi Y; Choi J
Nanoscale Adv; 2023 Mar; 5(7):1853-1869. PubMed ID: 36998671
[TBL] [Abstract][Full Text] [Related]
12. Lipid-based nanoparticle formulations for small molecules and RNA drugs.
Ickenstein LM; Garidel P
Expert Opin Drug Deliv; 2019 Nov; 16(11):1205-1226. PubMed ID: 31530041
[No Abstract] [Full Text] [Related]
13. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
Francia V; Schiffelers RM; Cullis PR; Witzigmann D
Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
[TBL] [Abstract][Full Text] [Related]
15. Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery
Zhang T; Yin H; Li Y; Yang H; Ge K; Zhang J; Yuan Q; Dai X; Naeem A; Weng Y; Huang Y; Liang XJ
iScience; 2024 Jun; 27(6):109804. PubMed ID: 38770138
[TBL] [Abstract][Full Text] [Related]
16. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
[TBL] [Abstract][Full Text] [Related]
17. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
[TBL] [Abstract][Full Text] [Related]
18. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles.
Ross-Thriepland D; Bornot A; Butler L; Desai A; Jaiswal H; Peel S; Hunter MR; Odunze U; Isherwood B; Gianni D
SLAS Discov; 2020 Jul; 25(6):605-617. PubMed ID: 32441189
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects.
Kon E; Ad-El N; Hazan-Halevy I; Stotsky-Oterin L; Peer D
Nat Rev Clin Oncol; 2023 Nov; 20(11):739-754. PubMed ID: 37587254
[TBL] [Abstract][Full Text] [Related]
20. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.
Evers MJW; Du W; Yang Q; Kooijmans SAA; Vink A; van Steenbergen M; Vader P; de Jager SCA; Fuchs SA; Mastrobattista E; Sluijter JPG; Lei Z; Schiffelers R
J Control Release; 2022 Mar; 343():207-216. PubMed ID: 35077739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
